Table 3.
Percentage of Follow-up Time Spent in Various Clinical States or During Which Patients Were on Antipsychotic Medications, Butajira, Ethiopia
| No. of Patients | % Time Spent in Different Clinical and Treatment States |
|||||||
| 0 | 1–5 | 6–15 | 16–45 | 46–75 | 76–100 | Total | ||
| Clinical state | ||||||||
| Complete remission | 318 | 30.8 | 4.4 | 17.3 | 30.2 | 11.6 | 5.7 | 100.0 |
| Partial remission | 318 | 38.1 | 17.0 | 20.4 | 19.8 | 3.8 | 0.9 | 100.0 |
| Psychotic episode | 318 | 22.0 | 36.8 | 28.6 | 11.3 | 0 | 1.3 | 100.0 |
| Antipsychotic medication | ||||||||
| Any medication | 318 | 9.1 | 22.0 | 18.2 | 26.1 | 11.6 | 12.9 | 100.0 |
| Oral medication | 318 | 12.6 | 26.4 | 23.3 | 22.6 | 6.9 | 8.2 | 100.0 |
| Injectibles | 318 | 72.6 | 11.6 | 6.9 | 7.9 | 0.9 | 0 | 100.0 |
| Both oral and injections | 318 | 75.2 | 11.0 | 7.5 | 3.8 | 2.2 | 0.3 | 100.0 |